ASX:API

Australian Pharmaceutical Industries Stock Forecast, Price & News

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Volume453,647 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend Yield2.63%
BetaN/A

Receive API News and Ratings via Email

Sign-up to receive the latest news and ratings for Australian Pharmaceutical Industries and its competitors with MarketBeat's FREE daily newsletter.


About Australian Pharmaceutical Industries

Australian Pharmaceutical Industries Limited engages in the wholesale distribution of pharmaceutical, medical, health, beauty, and lifestyle products to pharmacies primarily in Australia. It also retails health and beauty products to consumers through a network of Priceline and Priceline Pharmacy franchise stores, and company owned Priceline stores in Australia; sells beauty products through Clear Skincare network of clinics in Australia and New Zealand; and manufactures and distributes pharmaceutical and toiletry goods to New Zealand, Australian, and Asian markets, as well as provides cosmetic products and non-invasive aesthetic beauty services. The company was founded in 1910 and is based in Camberwell, Australia.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank

Overall MarketRank

1.02 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.3Dividend Strength: 0.8Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Australian Pharmaceutical Industries (ASX:API) Frequently Asked Questions

What stocks does MarketBeat like better than Australian Pharmaceutical Industries?

Wall Street analysts have given Australian Pharmaceutical Industries a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Australian Pharmaceutical Industries wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Australian Pharmaceutical Industries' next earnings date?

Australian Pharmaceutical Industries is scheduled to release its next quarterly earnings announcement on Friday, October 22nd 2021.
View our earnings forecast for Australian Pharmaceutical Industries
.

How were Australian Pharmaceutical Industries' earnings last quarter?

Australian Pharmaceutical Industries Limited (ASX:API) announced its quarterly earnings data on Wednesday, April, 17th. The company reported $0.05 EPS for the quarter, missing the Zacks' consensus estimate of $0.05 by $0.00.
View Australian Pharmaceutical Industries' earnings history
.

How often does Australian Pharmaceutical Industries pay dividends? What is the dividend yield for Australian Pharmaceutical Industries?

Australian Pharmaceutical Industries announced a Interim dividend on Friday, April 23rd. Investors of record on Thursday, June 3rd will be paid a dividend of 0.015 per share on Thursday, June 3rd. This represents a dividend yield of 1.16%. The ex-dividend date of this dividend is Wednesday, May 5th.
View Australian Pharmaceutical Industries' dividend history
.

Is Australian Pharmaceutical Industries a good dividend stock?

Australian Pharmaceutical Industries pays an annual dividend of A$0.04 per share and currently has a dividend yield of 2.63%.
View Australian Pharmaceutical Industries' dividend history.

Who are Australian Pharmaceutical Industries' key executives?

Australian Pharmaceutical Industries' management team includes the following people:
  • Mr. Richard C. Vincent C.P.A., B.Bus, (Accountancy), CPA, MD, CEO & Exec. Director
  • Mr. Peter Mendo, Chief Financial Officer
  • Mr. Dean Matthews, Chief Information Officer
  • Ms. Anne Mustow B.Com., L.L.B., Gen. Counsel & Company Sec.
  • Mr. Stephen Arthurson, Gen. Mang. of People
  • Mr. D. Glance, NSW State Mang.

Who are some of Australian Pharmaceutical Industries' key competitors?

What other stocks do shareholders of Australian Pharmaceutical Industries own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Australian Pharmaceutical Industries investors own include Capricorn Metals (CMM), Austal (ASB), Mod Resources (MOD), Harvey Norman (HVN), Evolution Mining (EVN) and Downer EDI (DOW).

What is Australian Pharmaceutical Industries' stock symbol?

Australian Pharmaceutical Industries trades on the ASX under the ticker symbol "API."

How much money does Australian Pharmaceutical Industries make?

Australian Pharmaceutical Industries has a market capitalization of $0.00 and generates $3.97 billion in revenue each year.

What is Australian Pharmaceutical Industries' official website?

The official website for Australian Pharmaceutical Industries is www.api.net.au.

Where are Australian Pharmaceutical Industries' headquarters?

Australian Pharmaceutical Industries is headquartered at L 5 250 Camberwell Rd, MELBOURNE, VIC 3124, Australia.

How can I contact Australian Pharmaceutical Industries?

Australian Pharmaceutical Industries' mailing address is L 5 250 Camberwell Rd, MELBOURNE, VIC 3124, Australia. The company can be reached via phone at +61-3-88553000.


This page was last updated on 9/17/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.